Crossmark

Immune-related adverse events (irAEs) in ankylosing spondylitis (AS) patients treated with interleukin (IL)-17 inhibitors: a systematic review and meta-analysis

Crossref DOI link: https://doi.org/10.1007/s10787-022-00933-z

Published Online: 2022-02-21

Published Print: 2022-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Azadeh, Hossein

Alizadeh-Navaei, Reza

Rezaiemanesh, Alireza

Rajabinejad, Misagh https://orcid.org/0000-0002-1217-2059
License Information

Text and Data Mining valid from 2022-02-21

Version of Record valid from 2022-02-21
More Information

Article History

Received: 19 January 2022

Accepted: 3 February 2022

First Online: 21 February 2022

Declarations

:

: The authors declare that they have no conflicts of interest.

: Not applicable.

: Not applicable.

Document is current

Any future updates will be listed below